GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (FRA:OFK) » Definitions » Institutional Ownership

Orion Oyj (FRA:OFK) Institutional Ownership : 23.61% (As of May. 23, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Orion Oyj Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Orion Oyj's institutional ownership is 23.61%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Orion Oyj's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Orion Oyj's Float Percentage Of Total Shares Outstanding is 0.00%.


Orion Oyj Institutional Ownership Historical Data

The historical data trend for Orion Oyj's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Institutional Ownership Chart

Orion Oyj Historical Data

The historical data trend for Orion Oyj can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 23.02 23.28 23.72 23.57 23.66 23.96 24.03 23.45 23.70 23.61

Orion Oyj Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Orion Oyj (FRA:OFK) Business Description

Address
Orionintie 1, P.O. Box 65, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.

Orion Oyj (FRA:OFK) Headlines

No Headlines